that a clinical trial for its antibody treatment for Covid-19 has been paused because of a “potential safety concern,” just one day after Johnson & Johnson halted its Covid-19 vaccine trial because a participant got sick.Eli Lilly is testing how hundreds of people hospitalized with Covid-19 react to its antibody therapy compared with a placebo; all study participants also receive the experimental drug remdesivir.
Multiple government officials reportedly sent emails to researchers Tuesday to tell them to stop enrolling new participants out of an “abundance of caution,” according to thethe company supports the decision the independent oversight committee Data and Safety Monitoring Board made to pause the study to “cautiously ensure” the safety of participants.
Great... Another pump in the making